Breadcrumb

What’s new at The Institute?

Three Institute and MUHC projects selected for the Digital Health Innovation Fund

Three teams associated with the McGill University Health Centre (MUHC) and The Institute will contribute...

A Canadian first: Volunteers intentionally exposed to influenza to advance vaccine research

Conducted in specialized research units in Montreal and Halifax, the study aims to accelerate vaccine evaluation while...

Dr. Rhian M. Touyz reappointed to lead the Research Institute of the McGill University Health Centre

The Board of Directors has renewed Dr. Touyz’s mandate as Chief Scientific Officer for a further three years...

Researchers create a beating “mini-heart” from a patient’s blood cells

Developed at The Institute, the 3D heart-on-a-chip model reproduces key features of dilated cardiomyopathy and could help researchers identify...

Healthier fats linked to longer survival after prostate cancer diagnosis

Study conducted at Harvard T.H. Chan School of Public Health and The Institute finds that replacing saturated...

A new sarcoma clinical trial bridges adolescent and adult care at the MUHC

Highlighting the MUHC’s unique ability to bridge pediatric and adult cancer care, the trial evaluates a new...

Valuing abilities: Eight interns with disabilities and their host teams build a more inclusive Institute

Ariane Richard-Massé is one of the interns living with disabilities who joined The Institute in 2026...

Putting a price on saving lives: The Institute study reveals what it really costs to diagnose deadly blood infections in Africa

Picture a district hospital in sub-Saharan Africa. A child arrives with a high fever...

Generic semaglutide could reshape diabetes drug coverage in Canada

Lower-cost medication dramatically improves the cost-effectiveness of treatment that helps prevent heart and kidney disease

Learn more about the RI-MUHC